Cargando…

The novel partnership of L-GILZ and p53: a new affair in cancer?

A recent report from our laboratory reveals how long glucocorticoid-induced leucine zipper (L-Gilz) protein binds to p53 and mouse double minute 2 homolog (Mdm2), thus dissociating the p53/Mdm2 complex and activating p53 with subsequent activation of downstream genes p21 and p53 upregulated modulato...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ayroldi, Emira, Marchetti, Cristina, Riccardi, Carlo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2014
Materias:	Author'S View
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4905020/ https://www.ncbi.nlm.nih.gov/pubmed/27308427 http://dx.doi.org/10.4161/23723556.2014.975087

Ejemplares similares

Implicating the Role of GILZ in Glucocorticoid Modulation of T-Cell Activation
por: Cannarile, Lorenza, et al.
Publicado: (2019)

A focused Real Time PCR strategy to determine GILZ expression in mouse tissues
por: Cari, Luigi, et al.
Publicado: (2015)

Bcl-xL overexpression decreases GILZ levels and inhibits glucocorticoid-induced activation of caspase-8 and caspase-3 in mouse thymocytes
por: Muscari, Isabella, et al.
Publicado: (2020)

p53 isoforms change p53 paradigm
por: Bourdon, JC
Publicado: (2014)

TRIM32 is a novel negative regulator of p53
por: Liu, Juan, et al.
Publicado: (2014)

A novel facet of tumor suppression by p53: Induction of tumor immunogenicity
por: Li, Hai, et al.
Publicado: (2012)

PBRM1 suppresses tumor growth as a novel p53 acetylation reader
por: Cai, Weijia, et al.
Publicado: (2020)

Cdk6: At the interface of Rb and p53
por: Nebenfuehr, Sofie, et al.
Publicado: (2018)

Endosome traffic machinery meets the p53–p21 axis
por: Barroso-González, Jonathan, et al.
Publicado: (2014)

Treating cancer when pRb and p53 cannot be reactivated
por: Zhu, Liang
Publicado: (2015)

Androgen receptor, ccl2, and epithelial-mesenchymal transition: A dangerous affair in the tumor microenvironment
por: Lin, Wen-Jye, et al.
Publicado: (2014)

Cytoplasmic gain-of-function mutant p53 contributes to inflammation-associated cancer
por: Bellazzo, Arianna, et al.
Publicado: (2015)

Protective role of p53 in doxorubicin-induced cardiomyopathy as a mitochondrial disease
por: Nishi, Masahiro, et al.
Publicado: (2020)

The complex role of SIRT7 in p53 stabilization: nucleophosmin joins the debate
por: Kumari, Poonam, et al.
Publicado: (2021)

p53 and RB1 regulate Hedgehog responsiveness via autophagy-mediated ciliogenesis
por: Cain, Jason E., et al.
Publicado: (2020)

The pan-cancer lncRNA MILIP links c-Myc to p53 repression
por: Feng, Yu Chen, et al.
Publicado: (2020)

Regulation of Innate Lymphoid Cells in Acute Kidney Injury: Crosstalk between Cannabidiol and GILZ
por: Baban, Babak, et al.
Publicado: (2020)

Inhibiting system x(C)(−) and glutathione biosynthesis – a potential Achilles' heel in mutant-p53 cancers
por: Clemons, Nicholas J., et al.
Publicado: (2017)

GILZ as a Regulator of Cell Fate and Inflammation
por: Bruscoli, Stefano, et al.
Publicado: (2021)

GILZ as a Mediator of the Anti-Inflammatory Effects of Glucocorticoids
por: Ronchetti, Simona, et al.
Publicado: (2015)

NKp44L: A new tool for fighting cancer
por: Vieillard, Vincent, et al.
Publicado: (2014)

Interleukin-30: A novel microenvironmental hallmark of prostate cancer progression
por: Di Carlo, Emma
Publicado: (2014)

Novel role of p73 as a regulator of developmental angiogenesis: Implication for cancer therapy
por: Marin, Maria C, et al.
Publicado: (2015)

Gender, mutant p53 and PML: A growing “affaire” in tumor suppression and oncogenesis
por: Di Agostino, Silvia, et al.
Publicado: (2013)

A novel combinatorial cancer immunotherapy: poly-IC and blockade of the PD-1/PD-L1 pathway
por: Nagato, Toshihiro, et al.
Publicado: (2014)

Glucocorticoid-induced leucine zipper (GILZ)/NF-κB interaction: role of GILZ homo-dimerization and C-terminal domain
por: Marco, Barbara Di, et al.
Publicado: (2007)

New role for antigen-presenting activated pDCs in promoting Th17 cells and impacting antitumor immunity
por: Guéry, Leslie, et al.
Publicado: (2015)

A dual role for glucocorticoid-induced leucine zipper in glucocorticoid function: tumor growth promotion or suppression?
por: Ayroldi, Emira, et al.
Publicado: (2018)

The role of soluble CD40L in immunosuppression
por: Schlom, Jeffrey, et al.
Publicado: (2013)

A novel miRNA-mediated STOP sign in lung cancer: miR-340 inhibits the proliferation of lung cancer cells through p27(KIP1)
por: Fernandez, Serena, et al.
Publicado: (2015)

Clarifying the pharmacodynamics of tecemotide (L-BLP25)-based combination therapy
por: Kao, Chiao-Jung, et al.
Publicado: (2013)

Structure and function of a monocarboxylate transporter homolog specific for L-lactate
por: Bosshart, Patrick D., et al.
Publicado: (2019)

Targeting endosomal pH for cancer chemotherapy
por: Lucien, Fabrice, et al.
Publicado: (2018)

p16: cycling off the beaten path
por: Buj, Raquel, et al.
Publicado: (2019)

MicroRNAs as novel immunotherapeutics
por: Heimberger, Amy B, et al.
Publicado: (2013)

L-BLP25 vaccine plus letrozole for breast cancer: Is translation possible?
por: DeGregorio, Michael, et al.
Publicado: (2012)

PD-L1 immune suppression in cancer: Tumor cells or host cells?
por: Kleinovink, Jan Willem, et al.
Publicado: (2017)

Glucocorticoid-Induced Leucine Zipper (GILZ) in Cardiovascular Health and Disease
por: Cappetta, Donato, et al.
Publicado: (2021)

Novel insights into the epigenetics of diffuse glioma
por: Danussi, Carla, et al.
Publicado: (2018)

Cytosolic pH: A conserved regulator of cell growth?
por: Dechant, Reinhard, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_m9cbrere6tqr4u99mgh1jhujjg